Purpose of this Study
We are doing this study to learn more about prostate cancer and whether certain treatments are related with different outcomes and patient experiences.
Who Can Participate?
Eligibility
Adult patients who have advanced prostate cancer
What is Involved?
If you choose to join this study, you will:<ul>
<li>Have your cancer-related experiences tracked as you undergo standard treatment for your prostate cancer</li>
<li>Answer questions about your treatment and experience every three months for two years then every six months for a minimum of three years</li>
<li>Have blood samples that will be collected before study entry, at each treatment change, after 1 year of participation, and after 2 years of participation</li></ul>
<li>Have your cancer-related experiences tracked as you undergo standard treatment for your prostate cancer</li>
<li>Answer questions about your treatment and experience every three months for two years then every six months for a minimum of three years</li>
<li>Have blood samples that will be collected before study entry, at each treatment change, after 1 year of participation, and after 2 years of participation</li></ul>
Study Details
Full Title
IRONMAN: International Registry for Men with Advanced Prostate Cancer
Principal Investigator
Daniel
George
Protocol Number
PRO00080554
NCT ID
NCT03151629
Phase
N/A
Enrollment Status
Open to Enrollment